1-Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010; 12(2–3):e86–96.
2- Moe OW. Kidney stones: pathophysiology and medical management. Lancet 2006; 367(9507):333–44
3- Scales CD, Lin L, Saigal CS, Bennett CJ, Ponce NA, Mangione CM, et al. Emergency Department Revisits for Patients with Kidney Stones in California. Acad Emerg Med. 2015; 22(4):468–74.
4- Türk C, Neisius A, Petrik A, Seitz C, Skolarikos A, Tepeler A, et al. Guidelines on urolithiasis. European Association of Urology. 2017. https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urolithiasis_2017_10–05V2.pdf.
5-Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, et al. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl. 2015; 87(2):105–20.
6- Trinchieri A. Diet and renal stone formation. Minerva Med. 2013; 104(1):41–54.
7- Noori N, Honarkar E, Goldfarb DS, Kalantar-Zadeh K, Taheri M, Shakhssalim N, et al. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis. 2014; 63(3):456–63.
8- Cheungpasitporn W, Rossetti S, Friend K, Erickson SB, Lieske JC. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. 2016; 29(2):211–219.
9- Hollingsworth J, Yan PL, Hollenbeck BK, Ghani KR. Follow-up care after ED visits for kidney stones—a missed opportunity. Eur Urol Suppl. 2017;16(3):e720.
10- Akel M, Cherfan M, Safwan J, Sakr F, Dabbous M, Shamsedeen L, et al. An Overview of Kidney Stone Disease in Lebanon. Global J. Pharmacol.2016; 10 (4): 89–97.
11- Scales CD Jr, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–5.
12- Pearle MS, Calhoun EA, Curhan GC, Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol. 2005; 173(3):848–57.
13- Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.Eur Urol. 2003; 44(6):709–13.
14-Chandhoke PS. Evaluation of the recurrent stone former. Urol Clin North Am. 2007; 34(3):315–22.
15- Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.
16-Gul Z, Monga M. Medical and Dietary Therapy for Kidney Stone Prevention. Korean J Urol. 2014; 55(12):775–779.
17-Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009; 56(1):72–80.
18- Brown J. Diagnostic and treatment patterns for renal colic in US emergency departments. Int Urol Nephrol 2006;38(1):87–92.
19- Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012; 307(14):1513–6.
20- Luckenbaugh AN, Yan PL, Dauw CA, Ghani KR, Hollenbeck BK, Hollingsworth JM. Follow-Up Care After Emergency Department Visits for Kidney Stones: A Missed Opportunity.Urol Pract. 2019; 6(1):24–28.
21- Bos D, Kim K, Hoogenes J, Lambe S, Shayegan B, Matsumoto ED. Compliance of the recurrent renal stone former with current best practice guidelines. Can Urol Assoc J. 2018; 12(3):E112-E120.
22- Dauw CA, Yi Y, Bierlein MJ, Yan P, Alruwaily AF, Ghani KR, et al. Factors associated with preventative pharmacological therapy adherence among patients with kidney stones. Urology. 2016; 93:45–49.
23-Chan SW, Ng CF, Man CW, Chung R, Li SK. A report on a randomly sampled questionnaire survey about renal stone disease in Hong Kong. Hong Kong Med J. 2008; 14(6):427–31.